Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Sennosides has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Sennosides A and B are both prodrugs. Bacterial beta-glucosidase releases the dianthrone, which is then reduced to rhein anthrone in the colon. Someone with a heavily disrupted colonic flora converts less of the same dose. This is settled pharmacology and it explains most of the person-to-person variability.
The colon normally reclaims potassium along with water. Faster transit with more luminal fluid leaves less opportunity for that. Repeated use over weeks is where blood potassium drops enough to matter, and it is a laboratory finding before it is a felt one. This is one of the strongest arguments for limiting the class to short courses.
Psyllium works mechanically by holding water and adding stool mass, and it holds up over long periods. Sennosides act on enteric nerves and colonic secretion and are designed for short use. Building the routine on fibre and reserving the stimulant for occasional use is the usual structure. The two taken together at the same moment make it harder to tell which is producing what.
Two different mechanisms converging on the same output stack rather than cancel. People often do not count a magnesium citrate supplement as part of their laxative load. Combining them also compounds fluid loss. Doses matter here: supplemental magnesium for other purposes is far below the osmotic laxative range.
Calcium absorption is a slow, partly saturable process that depends on contact time with the intestinal surface. Faster transit shortens that window. The direction is clear from mechanism; the magnitude in ordinary intermittent use has not been well quantified. Separating mineral doses from laxative timing sidesteps it.
Glycyrrhizin blocks 11-beta-hydroxysteroid dehydrogenase type 2, letting cortisol act at the mineralocorticoid receptor and driving potassium out through the kidney. Sennosides drive it out through the stool. Both routes at once is a real additive risk that crosses product categories. Deglycyrrhizinated licorice extracts do not carry it.
Cramping is the common complaint with stimulant laxatives, and the traditional formulation answer was a spasmolytic herb in the same cup. Chamomile, fennel and peppermint are the usual choices. The pairing is formulation convention with a plausible mechanism, not a trialled combination. It does not change conversion or potency.
Nothing specific on file for Sennosides. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Sennosides. The full linked list is below.
1 source behind our Sennosides verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 184,528 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Sennosides is, not how risky it is. A report is not proof Sennosides caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.